CONTRIBUTORS TO THIS VOLUME SALVATORE DIMAURO KARL HEINZ GLÄTZER C. A. HECKMAN NORBERT KOCIOK ALBERT LEIBOVITZ WlNFRID LlEBRICH ARMAND F. MIRANDA TlZIANA MONGINI PAUL J. PRICE J.-M. QUIOT SHAUL REUVENY LYNNE P. RUTZKY C. VAGO A. VEY Advances in CELL CULTURE Edited by KARL MARAMOROSCH Robert L. Starkey Professor of Microbiology Waksman Institute of Microbiology Rutgers University New Brunswick, New Jersey VOLUME 4 1985 ACADEMIC PRESS, INC. (Harcourt Brace Jovanovich, Publishers) Orlando San Diego New York London Toronto Montreal Sydney Tokyo COPYRIGHT © 1985, BY ACADEMIC PRESS, INC. ALL RIGHTS RESERVED. NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR TRANSMITTED IN ANY FORM OR BY ANY MEANS, ELECTRONIC OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT PERMISSION IN WRITING FROM THE PUBLISHER. ACADEMIC PRESS, INC. Orlando, Florida 32887 United Kingdom Edition published by ACADEMIC PRESS INC. (LONDON) LTD. 24-28 Oval Road, London NW1 7DX ISSN Ο275-6358 ISBN 0-12-007904-6 PRINTED IN THE UNITED STATES OF AMERICA 85 86 87 88 9 8 7 6 5 4 3 2 1 CONTRIBUTORS TO VOLUME 4 Numbers in parentheses indicate the pages on which the authors' contributions begin. SALVATORE DIMAURO (1), Department of Neurology, Columbia Univer- sity, College of Physicians and Surgeons, and the H. Houston Mer- ritt Clinical Research Center for Muscular Dystrophy and Related Diseases, New York, New York 10032 KARL HEINZ GLÄTZER (179), Institut für Genetik, Universität Düsseldorf, D-4000 Düsseldorf, Federal Republic of Germany C. A. HECKMAN (85), Department of Biological Sciences, Bowling Green State University, Bowling Green, Ohio 43403 NORBERT KOCIOK (179), Institut für Genetik, Universität Düsseldorf, D-4000 Düsseldorf, Federal Republic of Germany ALBERT LEIBOVITZ (249), Arizona Cancer Center, University of Arizona College of Medicine, Tucson, Arizona 85724 WINFRID LIEBRICH (179), Institut für Genetik, Universität Düsseldorf, D-4000 Düsseldorf, Federal Republic of Germany ARMAND F. MIRANDA (1), Department of Pathology, Columbia Univer- sity, College of Physicians and Surgeons, and the H. Houston Mer- ritt Clinical Research Center for Muscular Dystrophy and Related Diseases, New York, New York 10032 TIZIANA MONGINI (1), Department of Neurology, Columbia University, College of Physicians and Surgeons, and the H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Dis- eases, New York, New York 10032 PAUL J. PRICE (157), Hybridoma Sciences, Inc., Atlanta, Georgia 30084 J.-M. QUIOT (199), Centre de Recherches de Pathologie Comparée, INRA, CNRS, USTL, 30380 Saint-Christol, France SHAUL REUVENY l (213), Department of Biotechnology, Israel Institute for Biological Research, Ness-Ziona 70450, Israel LYNNE P. RUTZKY (47), Department of Surgery, The University of Texas Medical School, Houston, Texas 77030 C. VAGO (199), Centre de Recherches de Pathologie Comparée, INRA, CNRS, USTL, 30380 Saint-Christol, France A. VEY (199), Centre de Recherches de Pathologie Comparée, INRA, CNRS, USTL, 30380 Saint-Christol, France 1Present address: New Brunswick Scientific Co., Inc., 44 Talmadge Rd., Edison, New Jersey 08818. IX PREFACE Volume 4 of Advances in Cell Culture continues the wide coverage of this serial publication. Chapters are devoted to basic aspects such as cell shape and growth control in vitro, morphological and cytochemical changes occurring during muscle culture of human myopathies, and the biology of cultured human colon tumor cells. Among the important practical topics are the structure and application of microcarriers and hybridoma technology. One chapter is devoted to the establishment of cell lines from human solid tumors. The use of invertebrate organ culture for the study of spermiogenesis and the study of mycotoxin action on invertebrate cells are presented in two chapters. Readers will find stimulating ideas, new concepts, and fresh approaches to problems in the current contributions. Facets of cell culture that may have im- mediate, as well as long-range economic potential, are presented. The contributions reflect the thinking and accomplishments of those who are in the forefront of the broad field of cell culture today. The depth and sophistication of the articles indicate current strength in the di- verse areas of in vitro research. In this volume, a biographical sketch has been devoted to George Gey, who had a profound impact on cell culture and on numerous scientists who became inspired by him. KARL MARAMOROSCH XI GEORGE GEY Xll GEORGE GEY Xll DREAMS OF CELLULAR PHYSIOLOGY IN TISSUE CULTURE: GEORGE GEY S BEQUEST In 1923, Dr. John L. Yates, a graduate of The Johns Hopkins Univer- sity School of Medicine and Chief of Surgery at Columbia Hospital in Milwaukee, Wisconsin, and whose interest was in cancer of the breast, wrote to Dr. Warren Lewis of the Carnegie Institution at The Johns Hopkins Medical School asking for scientists trained in tissue culture to come to establish a tissue culture facility in Milwaukee. At this time, George Gey, who had worked part time in this field, was a first- year medical student at Johns Hopkins. Chance would have it that George's funds for medical school had been depleted before finishing his second year, and Dr. Warren Lewis suggested that he take the position at Columbia Hospital. In September 1923, George transferred to Milwaukee. He asked Margaret Koudelka, at that time the operat- ing room supervisor, to assist him in sterilization in his new laborato- ry, which consisted of two small rooms, one a sterile room and the other an office. George obtained the services of two Milwaukeeans, whom he trained in tissue culture and in handling laboratory animals and laboratory technical design. From 1923 to 1926, George Gey built a laboratory and a more than strong friendship with Margaret Koudelka. In 1926, George married Margaret, and the two initiated a scientific career which took them all over the country and blessed them with two won- derful children, George, Jr., and Frances. It was clear that George was going to return to Johns Hopkins to complete his medical school training, and after six years in Mil- waukee, he did indeed return to Baltimore with his new wife where he was to return to his medical studies and simultaneously develop a tissue culture laboratory in the Carnegie Institution. Dr. Joseph Bloodgood and Dr. Warren Lewis facilitated this joint endeavor. From the ground level George and Margaret physically built their laborato- ry on the first floor of the Carnegie Institution building from an old janitor's quarters of three rooms and a bathroom. A cubicle and an incubator were moved into the space in which the janitor's bathroom had been torn out. It was cleaned and painted, and a drying oven, an autoclave, a small sink, and a laboratory work table were personally installed by Dr. George Gey. Dr. Dean Lewis, the Professor of Surgery, Dr. Woodrich Williams, the Professor of Obstetrics and Gynecology, and Dr. Bloodgood joined in providing the biological resources neces- sary to obtain tissue culture specimens for this work. In 1931, Bill Xlll XIV GEORGE GEY Fitzwilliams and Tom Stark, two of George Gey's original technicians in Milwaukee, were hit by the economic depression, and quickly moved to Baltimore to continue to assist in the development of this pioneering tissue culture endeavor. At the same time, Dr. and Mrs. Dean Lewis invited Dr. Gey and Mrs. Gey to conduct summer experiments in Salis- bury Cove, Maine, which would require moving the tissue culture equipment to conduct this work. The laboratory was in an old farm- house. Margaret and George lived in a tent on the grounds throughout the summer. In 1932, Carl Koudelka, Margaret's brother from Mil- waukee joined them. Later, Tom Stark was to join Dr. Wilton Earl at the National Institutes of Health, but Bill Fitzwilliams stayed on with the Gey's for forty-three years. George received his medical degree from The Johns Hopkins Medical School in 1933. It was in this year that he, in the laboratory, increased the growth of cells by converting from the old Maximow Hanging Drop methods to the now famous "roller tube" technique of tissue culture that he pioneered. This was the method that was used later to establish the HeLa cell. In 1939, Dr. George Körner became director of the Carnegie Labora- tories, and Dr. Gey moved his laboratories to the Department of Sur- gical Pathology with Dr. Warfield Firor and Dr. Bloodgood. This new move into the Department of Surgical Pathology meant new construc- tion. George Gey did the construction himself. He built three cubicles of brick, cement, glass, and stainless steel with incubators, animal rooms, cleanup and washing rooms to mold a tissue culture system that attracted fellows and scientists from all over the world to learn the Gey tissue culture techniques. The laboratory remained in the Surgical Pathology section until the new Director of the Department of Surgery, Dr. Alfred Blaloch, was appointed. Then the laboratory moved into the Blaloch Building. The Gey laboratory was given the thirteenth floor, and work began again to build new and expanded laboratories. These laboratories were occupied until George Gey's death on November 8, 1970. It was in this laboratory that the HeLa cell was established. Numerous other contributions to medical science were made from these portals, and many scientists were trained for work in their own institutions world wide. It was in these laboratories that the BeWo Trophoblast cell line was established by Dr. Gey's last fellow, another Milwaukeean, Roland A. Pattillo, who had come to Hopkins in 1965. On February 1, 1951, a thirty-one-year-old black woman who com- plained of intermenstrual spotting appeared in the Gynecologic Outpa- GEORGE GEY xv tient Department of The Johns Hopkins Hospital. Eight days later, the resident gynecologist who saw her obtained a cervical biopsy on the patient, Henrietta Laacks, made it available to Dr. George Gey, who established the immortality of a cancer victim dead since 1951 in the tissue culture laboratory. This was the first human cell line to be established, and was widely distributed throughout the world for sci- entific research. It formed the groundwork on which poliovirus could be grown and led to the ultimate solution of the poliomyelitis crippling disease entity. It formed the basis for a wider and wider cell biological research system which spread all over the world. It provided the basic scientific investigative tool that brought together many nations in the joint effort to conquer human disease through in vitro techniques. The HeLa cells rapid and sometimes uncontrollable growth charac- teristics made it a ready source of human cells for investigation of almost every facet of human biology. By the same token, however, this rapid and almost uncontrollable growth generated enormous problems when contamination of many other cell lines around the world led to the discoveries of Gartler and Nelson-Reese that HeLa cells contami- nated many cell lines thought to be other entities. In addition, the HeLa cell line was carried for many years as an epidermoid carcinoma of the cervix only to have Dr. Howard Jones, a gynecologist who was the first to see Henrietta Laacks, along with the Hopkins pathologist, Dr. Donald Woodruff, review the original tumor from which the HeLa cell was derived and found it to be predominantly an adenocarcinoma of the cervix. Initially, in the 1930s and 1940s, Dr. Gey's laboratory, with the assistance of fellows that included Dr. Georgeanna Seeger Jones, em- barked on tissue culture efforts to establish hydatidiform moles, choriocarcinomas, and normal trophoblastic tissue in continuous culture. This cell type which secretes hCG would have hormone mark- er which could be detected in the culture media if a contamination with another cell type inadvertently occurred. This anticipated the problem of contamination that occurred in the HeLa cell systems. It was not until twenty-five years later that Dr. Roland Pattillo, in Dr. Gey's laboratory, established the BeWo cell line from a trophoblastic tumor which had been transplanted to the hamster cheek pouch by Dr. Roy Hertz at the National Institutes of Health. This cell line, a human chorionic gonadotropin producer, continues to produce hCG in continuous culture eighteen years after its estab- lishment. The "pregnancy hormone" secreted by these cells is detected by radioimmunoassay—rabbit, rat, mouse, frog, and other assays. Like HeLa, these cells have been distributed all over the world, but